Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Contact Us

Contact Us

Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Main office: +1 720 437 6500

General email inquiries: info@ampiopharma.com
Partnering email inquiries: partnering@ampiopharma.com

Ampion™

Ampion™ for the treatment of pain due to osteoarthritis of the knee.

Learn About Ampion

Optina™

Optina™ for the treatment of Diabetic Macular Edema.

Learn About Optina

Real Time Quote

Latest News

Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial

July 25, 2019

Ampio Appoints Moss Adams LLP as the Company’s New Independent Auditor

July 11, 2019

Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer

July 10, 2019
member-logo-85

© 2019 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us